相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
Theresa E. Hickey et al.
NATURE MEDICINE (2021)
The future of personalized brain stimulation
Martijn Figee et al.
NATURE MEDICINE (2021)
The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth
Daniela Bruennert et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response
Jihyun Kim et al.
MOLECULAR CANCER RESEARCH (2020)
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
Brian D. Lehmann et al.
CLINICAL CANCER RESEARCH (2020)
Clinical Imaging of the Heterogeneous Group of Triple-negative Breast Cancer
Martin Mueller et al.
ANTICANCER RESEARCH (2020)
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies
Ding Ma et al.
CANCER (2020)
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
Anna R. Michmerhuizen et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival
Hanane Mansouri et al.
CANCERS (2020)
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance
Shen Zhao et al.
ONCOLOGIST (2020)
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
Florence Coussy et al.
THERANOSTICS (2020)
Effect of AR antagonist combined with PARP1 inhibitor on sporadic triple-negative breast cancer bearing AR expression and methylation-mediated BRCA1 dysfunction
Meixiang Sang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Imaging features of triple-negative breast cancers according to androgen receptor status
Rosalind P. Candelaria et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
Aristomenis Anestis et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer
Anusha Angajala et al.
TRANSLATIONAL ONCOLOGY (2019)
Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
Barbara Adamo et al.
Oncotarget (2019)
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
Guillermo Prado-Vazquez et al.
SCIENTIFIC REPORTS (2019)
Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy
Lynn Jongen et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
Pia Giovannelli et al.
SCIENTIFIC REPORTS (2019)
The impact of distinct triple-negative breast cancer subtypes on misdiagnosis and diagnostic delay
C. Elfgen et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes
C. Elfgen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
Shristi Bhattarai et al.
CANCERS (2019)
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis o 263 Patients Treated With Standard Therapy for Stage I-III Disease
Maria Vittoria Dieci et al.
FRONTIERS IN ONCOLOGY (2019)
Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
Anita Mangia et al.
CANCERS (2019)
Enhancing Abiraterone Acetate Efficacy in Androgen Receptor-positive Triple-negative Breast Cancer: Chk1 as a Potential Target
Thomas Grellety et al.
CLINICAL CANCER RESEARCH (2019)
A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer
Gary H. Tozbikian et al.
HUMAN PATHOLOGY (2019)
Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
Yuan Chun Ding et al.
Oncotarget (2019)
LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer
Francesca Collina et al.
JOURNAL OF CANCER (2019)
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
Zachary J. Solomon et al.
SEXUAL MEDICINE REVIEWS (2019)
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Y. Bareche et al.
ANNALS OF ONCOLOGY (2018)
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers
Severine Guiu et al.
BRITISH JOURNAL OF CANCER (2018)
Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers
Sewha Kim et al.
CLINICAL BREAST CANCER (2018)
Strong androgen receptor expression can aid in distinguishing GATA3+metastases
Agedi Boto et al.
HUMAN PATHOLOGY (2018)
Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma
Aparna Harbhajanka et al.
HUMAN PATHOLOGY (2018)
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
Kristine Astvatsaturyan et al.
PLOS ONE (2018)
Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study
Ya-Xuan Liu et al.
ONCOLOGY LETTERS (2018)
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
Angela Santonja et al.
Oncotarget (2018)
Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature
Jia-wei Li et al.
SCIENTIFIC REPORTS (2018)
Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa 1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells
Anowara Khatun et al.
FRONTIERS IN PHYSIOLOGY (2018)
Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling
Khalid N. Al-Zahrani et al.
Oncotarget (2018)
200PClinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer
C H Park et al.
ANNALS OF ONCOLOGY (2018)
Androgen receptor expression in normal breast tissue and subsequent breast cancer risk
Kevin H. Kensler et al.
NPJ BREAST CANCER (2018)
Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer
Guilhem Roubaud et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Wei Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
Michael A. Gordon et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
Ayako Nakashoji et al.
ONCOLOGY LETTERS (2017)
Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer
Xiao-Qing Hu et al.
ONCOTARGET (2017)
Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer
Antonia K. Roseweir et al.
ONCOTARGET (2017)
Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
Yuka Asano et al.
CANCERS (2017)
The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer
Yan Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
Corey Speers et al.
NPJ BREAST CANCER (2017)
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
Uzma S. Asghar et al.
CLINICAL CANCER RESEARCH (2017)
Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma A 2015 Update
Ping Tang et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
A. Thakkar et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer
Andrew J. Robles et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
Yuka Asano et al.
BRITISH JOURNAL OF CANCER (2016)
Expression patterns of GATA3 and the androgen receptor are strongly correlated in patients with triple-negative breast cancer
Sewha Kim et al.
HUMAN PATHOLOGY (2016)
GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas
Drew G. Davis et al.
HUMAN PATHOLOGY (2016)
The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer
Jiayan Luo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Cooperative Dynamics of AR and ER Activity in Breast Cancer
Nicholas C. D'Amato et al.
MOLECULAR CANCER RESEARCH (2016)
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer
M. Pistelli et al.
ONCOLOGY REPORTS (2016)
GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy
Jason K. Wasserman et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin
Anna R. Kwilas et al.
ONCOTARGET (2016)
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Yi-Rong Liu et al.
BREAST CANCER RESEARCH (2016)
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer
Nadine Tung et al.
NPJ BREAST CANCER (2016)
Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression
Mona A. Abd-Elazeem et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2015)
A Targetable Androgen Receptor-Positive Breast Cancer Subtype Hidden Among the Triple-Negative Cancers
Damoun Safarpour et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Clinical implications of molecular heterogeneity in triple negative breast cancer
Brian D. Lehmann et al.
BREAST (2015)
Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer
Hanna Sartor et al.
CANCER CAUSES & CONTROL (2015)
The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer
Daniel Tamae et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications
Sherri Z. Millis et al.
CLINICAL BREAST CANCER (2015)
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial
Severine Guiu et al.
FUTURE ONCOLOGY (2015)
Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
Valerie N. Barton et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
Jung Eun Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Heterogeneity of triple-negative breast cancer: mammographic, US, and MR imaging features according to androgen receptor expression
Min Sun Bae et al.
EUROPEAN RADIOLOGY (2015)
Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
Paul J. Toren et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients
Giuseppina Rosaria Rita Ricciardi et al.
PLOS ONE (2015)
Androgen receptor and enzymes in lymph node metastasis and cancer reoccurrence in triple-negative breast cancer
Keely May McNamara et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2015)
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
Pascal Jezequel et al.
BREAST CANCER RESEARCH (2015)
Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype
Lee J. McGhan et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
Maria D. Cuenca-Lopez et al.
BMC CANCER (2014)
Androgen receptor phosphorylation: biological context and functional consequences
Yulia Koryakina et al.
ENDOCRINE-RELATED CANCER (2014)
Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer
Aye Aye Thike et al.
MODERN PATHOLOGY (2014)
Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
Pierluigi Gasparini et al.
PLOS ONE (2014)
Expression of Androgen Receptor and Its Association With Estrogen Receptor and Androgen Receptor Downstream Proteins in Normal/Benign Breast Luminal Epithelium
Xi Wang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
Mirco Pistelli et al.
CANCERS (2014)
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D. Lehmann et al.
BREAST CANCER RESEARCH (2014)
Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
Keely M. McNamara et al.
CANCER SCIENCE (2013)
The role of the androgen receptor in triple-negative breast cancer
Payal D. Shah et al.
WOMENS HEALTH (2013)
Expression and clinical significance of androgen receptor in triple negative breast cancer
Xiang Luo et al.
Chinese Journal of Cancer (2012)
Novel Developments in the Epidemic of Human Immunodeficiency Virus and Tuberculosis Coinfection
Asha Anandaiah et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Expression of androgen receptors in primary breast cancer
S. Park et al.
ANNALS OF ONCOLOGY (2010)
GATA3 in Development and Cancer Differentiation: Cells GATA Have It!
Jonathan Chou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
William P. Harris et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6
PL Toogood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
分享论文
